Dr. Vaishalee P. Kenkre
Claim this profileUniversity of Wisconsin Carbone Cancer Center
Area of expertise
Follicular Lymphoma
Vaishalee P. Kenkre has run 2 trials for Follicular Lymphoma. Some of their research focus areas include:
Central Nervous System Hodgkin Lymphoma
Vaishalee P. Kenkre has run 2 trials for Central Nervous System Hodgkin Lymphoma. Some of their research focus areas include:
Affiliated Hospitals
University Of Wisconsin - Carbone Cancer Center
University Of Wisconsin Carbone Cancer Center - University Hospital
Clinical Trials Vaishalee P. Kenkre is currently running
Tazemetostat + Rituximab + Bendamustine
for Follicular Lymphoma
This study is planned as a single arm clinical trial of tazemetostat in combination with bendamustine and rituximab with both a phase I and phase II component. All patients will receive tazemetostat twice daily on days 1-28 in combination with bendamustine 90 mg/m2 IV on days 1 and 2 and rituximab 375 mg/m2 IV on day 1 of a 28-day cycle for up to three cycles. Following this, patients will receive tazemetostat twice daily on days 1-28 and rituximab 375 mg/m2 IV on day 1 of a 28-day cycle for up to three cycles.
Recruiting
1 award
Phase 1 & 2
Nivolumab + Ruxolitinib
for Hodgkin's Lymphoma
This is a Phase I/II, multicenter, open-label, dose escalation/dose-expansion study to evaluate the tolerability, safety, and the maximum tolerated dose (MTD) of ruxolitinib when given with fixed dose nivolumab in patients with relapsed or refractory classical Hodgkin lymphoma (cHL).
Recruiting
1 award
Phase 1 & 2
More about Vaishalee P. Kenkre
Clinical Trial Related
6 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Vaishalee P. Kenkre has experience with
- Rituximab
- Nivolumab
- Autologous Hematopoietic Stem Cell Transplantation
- Doxorubicin Hydrochloride
- Bendamustine
- Tazemetostat
Breakdown of trials Vaishalee P. Kenkre has run
Follicular Lymphoma
Central Nervous System Hodgkin Lymphoma
Hodgkin's Lymphoma
Mantle Cell Lymphoma
Non-Hodgkin's Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Vaishalee P. Kenkre specialize in?
Vaishalee P. Kenkre focuses on Follicular Lymphoma and Central Nervous System Hodgkin Lymphoma. In particular, much of their work with Follicular Lymphoma has involved Stage II patients, or patients who are Stage III.
Is Vaishalee P. Kenkre currently recruiting for clinical trials?
Yes, Vaishalee P. Kenkre is currently recruiting for 2 clinical trials in Madison Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Vaishalee P. Kenkre has studied deeply?
Yes, Vaishalee P. Kenkre has studied treatments such as Rituximab, Nivolumab, Autologous Hematopoietic Stem Cell Transplantation.
What is the best way to schedule an appointment with Vaishalee P. Kenkre?
Apply for one of the trials that Vaishalee P. Kenkre is conducting.
What is the office address of Vaishalee P. Kenkre?
The office of Vaishalee P. Kenkre is located at: University of Wisconsin Carbone Cancer Center, Madison, Wisconsin 53705 United States. This is the address for their practice at the University of Wisconsin Carbone Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.